内蒙市白癜风哪最好浙江白癜风医院专科是哪家,浙江医院治疗白癜风价格,浙江治疗儿童白癜风的医院,山西治疗白癜风到哪家医院,北京怎样治疗好白癜风疾病,天津在线解答白癜风问题,河北看白癜风哪好

The U.S. government is officially investigating Facebook.The Federal Trade Commission confirmed in a statement Monday that it is currently investigating Facebook data practices as the company faces new scrutiny from the Cambridge Analytica scandal."The FTC takes very seriously recent press reports raising substantial concerns about the privacy practices of Facebook," said Tom Pahl, acting director of the FTC's Bureau of Consumer Protection. "Today, the FTC is confirming that it has an open non-public investigation into these practices."News broke earlier this month that Cambridge Analytica, a data firm with ties to President Donald Trump's campaign, reportedly accessed information from about 50 million Facebook users without their knowledge.CNN reported last week that the FTC was sending a letter to Facebook with questions about how the social media company allowed the data to wind up in the hands of Trump campaign consultants.Facebook stock was down 4% in early trading Monday.Reps for Facebook did not immediately respond to a request for comment.  1077

The University of Washington’s Institute for Health Metrics and Evaluation now projects that 68,000 American lives would be saved between now and March 1 by near universal wearing of masks.The IHME released the updated model on Thursday.The IHME’s coronavirus projections have been frequently cited in the past by the White House’s coronavirus task force. The group uses state data along with other metrics to create projections on the number of coronavirus-related deaths throughout the US.Among the projections released by the IHME, the number of active hospitalizations in the United States tied to the coronavirus is expected to double by mid-January.The COVID Tracking Project, a project led by The Atlantic, shows that current coronavirus-related hospitalizations hurdled the 60,000 mark in the US on Tuesday for the first time since the start of the pandemic. The number of people hospitalized with COVID-19 has more than doubled in the last six weeks throughout the US.By Friday, the number of people hospitalized with COVID-19 neared 70,000.A number of hospital systems in the US are nearing capacity already.And the IHME’s director Chris Murray warns that his estimates are on the conservative side.“The fall winter surge, you know, driven by people going indoors, having more indoor contact and, you know, it's what we've seen play out in Europe and now we're catching up,” Murray told CNN. “So we're seeing the huge exponential rise in cases, deaths starting to follow suit. We're already at over a thousand deaths a day, quite a bit more than that. So our numbers that see us getting to, you know, 2,200 deaths a day in mid-January, are perhaps conservative, and that does require 33 states to put in mandates. So, absolutely it can go much worse than that."Murray’s projection forecasts roughly an additional 200,000 coronavirus between now and March 1. The estimate drops to 132,000 if masks are nearly all situations outside of the household.By March 1, it’s possible that a number of high-risk Americans and health care workers will be vaccinated. The White House said on Friday that it intends on distributing 20 million vaccine doses by the end of December, and 25 to 30 million doses for each subsequent month. The vaccines would come in two doses. 2276

The White House has cut ties with a senior adviser to first lady Melania Trump after it was revealed the aide's firm was paid close to million to plan events around President Donald Trump's inauguration.The first lady's office said in a statement that it ended its contract with Stephanie Winston Wolkoff, who had been working as a special government employee."The Office of the First Lady severed the gratuitous services contract with Ms. Wolkoff. We thank her for her hard work and wish her all the best," said spokeswoman Stephanie Grisham.The New York Times first reported Wolkoff's departure.Inauguration committee tax documents revealed last week showed WIS Media Partners, a company based in Marina Del Ray, California, and founded by Wolkoff, received ,843,509 for "event production services."The roughly million the company received for its work on the inauguration was likely passed through to other vendors and event coordinators. The New York Times reported that Wolkoff personally received .62 million for her work.She told the Times on Monday that most of the million was paid to subcontractors, and that the .62 million was divided among 15 employees. Messages left by CNN with Wolkoff were not immediately returned.Last week, Grisham said Melania Trump "had no involvement" in planning the inauguration and had "no knowledge of how funds were spent."Trump and Wolkoff are longtime friends.  1438

The release of three US nationals currently detained in North Korea is "imminent," according to an official with knowledge of the ongoing negotiations.The official told CNN the North Koreans made the decision to free the Americans two months ago, and that North Korea's Foreign Minister Ri Yong Ho had proposed their release during his visit to Sweden in March.US officials insisted at the time that their release "must not be related or used to loosen the main issue of denuclearization," the source said. 519

The US Food and Drug Administration expanded?the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.New to the list are some valsartan products manufactured by Hetero Labs Ltd. in India, which are labeled as Camber Pharmaceuticals Inc. Test results show that some of the products may be tainted.The FDA announced a valsartan recall in July after lab tests revealed that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were affected.N-nitrosodimethylamine or NDMA, the impurity the lab tests found, is considered a?possible carcinogen by the US Environmental Protection Agency. It is an organic chemical that has been used to make liquid rocket fuel, and it can be unintentionally introduced through certain chemical reactions. It's a byproduct of the manufacturing of some pesticides and fish processing.The medicines that are now a part of this expanded list?in the recall are tablets sold by AvKare, A-S Medication Solutions LLC, Bryant Ranch Prepack Inc, Camber Pharmaceuticals, Inc. H J Harkins Company, Northwind Pharmaceuticals, NuCare Pharmaceuticals Inc., Prinston Pharmaceutical Inc. (labeled as Solco Healthcare LLC), Proficient Rx LP, Remedy Repack, Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis).The FDA also published a list of valsartan products that are not currently recalled. Only the drugs suspected of being tainted with NDMA are on the recall list. If you are taking a valsartan drug, look for the company name on your prescription bottle. If the information isn't on the label, you can call your pharmacy for those details.The recalled medicine is linked to a manufacturer in China. The substances were supplied by Zhejiang Huahai Pharmaceuticals, based in Linhai, in eastern China, which said it notified authorities as soon as it identified the impurity."We published our recall notice at midday on July 13 in China and overseas, and published the US market recall notice on July 14 Beijing time ... all the drug materials for the Chinese market were recalled by July 23," the company said in a statement to the Shanghai stock exchange last month.The FDA said on its website that it's working with drug manufacturers "to ensure future valsartan active pharmaceutical ingredients are not at risk."If you are worried that your drug could be on the recall list, talk with your doctor or pharmacist before changing any routine with your medicine. Because not all valsartan drugs are involved in the recall, they might be able to switch you to a version of the drug made by another company.If you know your drug is on the recall list, the FDA suggests you continue taking it until your doctor or pharmacist provides a replacement.To get a sense of what taking a tainted drug could mean, FDA scientists estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) from the recalled batches every day for four years, there may be one additional case of cancer."The key with this is, patients should not stop taking their medication abruptly, that definitely can be harmful," Dr. Mary Ann Bauman, a representative for the American Heart Association, said in July. "You don't want to jump to any conclusions on your own about this medication, or any medication for that matter. Definitely talk with your doctor first." 3690